Brian J Roach1, Judith M Ford2, Bruno Biagianti3, Holly K Hamilton4, Ian S Ramsay5, Melissa Fisher6, Rachel Loewy7, Sophia Vinogradov8, Daniel H Mathalon9. 1. San Francisco VA Healthcare System, United States of America. Electronic address: brian.roach@ncire.org. 2. University of California at San Francisco, United States of America; San Francisco VA Healthcare System, United States of America. Electronic address: Judith.ford@ucsf.edu. 3. University of California at San Francisco, United States of America. Electronic address: bruno.biagianti@positscience.com. 4. University of California at San Francisco, United States of America. Electronic address: holly.hamilton@ucsf.edu. 5. University of Minnesota, United States of America. Electronic address: ramsa045@umn.edu. 6. University of Minnesota, United States of America. Electronic address: mafisher@umn.edu. 7. University of California at San Francisco, United States of America. Electronic address: rachel.loewy@ucsf.edu. 8. University of Minnesota, United States of America. Electronic address: svinogra@umn.edu. 9. University of California at San Francisco, United States of America; San Francisco VA Healthcare System, United States of America. Electronic address: daniel.mathalon@ucsf.edu.
Abstract
INTRODUCTION: During vocalization, efference copy/corollary discharge mechanisms suppress the auditory cortical response to self-generated sounds as reflected in the N1 component of the auditory event-related potential (ERP). N1 suppression during talking is reduced in patients with schizophrenia. We hypothesized that these deficits would recover with auditory training that targets the speech processing system. METHODS:Forty-nine individuals early in the course of a schizophrenia-spectrum illness (ESZ) were randomly assigned to 40 h of Targeted Auditory Training (TAT; n = 23) or Computer Games (CG; n = 26). The N1 ERP component was elicited during production (Talk) and playback (Listen) of vocalization. Effects of Treatment on Global Cognition, N1 suppression (Talk-Listen), N1 during Talking and Listening were assessed. Simple effects of the passage of time were also assessed in the HC after 28 weeks. RESULTS: There was a Treatment × Time interaction revealing that N1 suppression was improved with TAT, but not with CG. TAT, but not CG, also improved Global Cognition. However, TAT and CG groups differed in their pre-treatment N1 suppression, and greater N1-suppression abnormalities were strongly associated with greater improvement in N1 suppression. CONCLUSIONS: In this sample of ESZ individuals, targeted auditory training appeared to improve the function of the efference copy/corollary discharge mechanism which tended to deteriorate with computer games. It remains to be determined if baseline N1 suppression abnormalities are necessary for TAT treatment to have a positive effect on efference copy/corollary discharge function or if improvements observed in this study represent a regression to the mean N1 suppression in ESZ. TRIAL REGISTRATION: ClinicalTrials.govNCT00694889. Registered 1 August 2007.
RCT Entities:
INTRODUCTION: During vocalization, efference copy/corollary discharge mechanisms suppress the auditory cortical response to self-generated sounds as reflected in the N1 component of the auditory event-related potential (ERP). N1 suppression during talking is reduced in patients with schizophrenia. We hypothesized that these deficits would recover with auditory training that targets the speech processing system. METHODS: Forty-nine individuals early in the course of a schizophrenia-spectrum illness (ESZ) were randomly assigned to 40 h of Targeted Auditory Training (TAT; n = 23) or Computer Games (CG; n = 26). The N1 ERP component was elicited during production (Talk) and playback (Listen) of vocalization. Effects of Treatment on Global Cognition, N1 suppression (Talk-Listen), N1 during Talking and Listening were assessed. Simple effects of the passage of time were also assessed in the HC after 28 weeks. RESULTS: There was a Treatment × Time interaction revealing that N1 suppression was improved with TAT, but not with CG. TAT, but not CG, also improved Global Cognition. However, TAT and CG groups differed in their pre-treatment N1 suppression, and greater N1-suppression abnormalities were strongly associated with greater improvement in N1 suppression. CONCLUSIONS: In this sample of ESZ individuals, targeted auditory training appeared to improve the function of the efference copy/corollary discharge mechanism which tended to deteriorate with computer games. It remains to be determined if baseline N1 suppression abnormalities are necessary for TAT treatment to have a positive effect on efference copy/corollary discharge function or if improvements observed in this study represent a regression to the mean N1 suppression in ESZ. TRIAL REGISTRATION: ClinicalTrials.govNCT00694889. Registered 1 August 2007.
Authors: J Kaufman; B Birmaher; D Brent; U Rao; C Flynn; P Moreci; D Williamson; N Ryan Journal: J Am Acad Child Adolesc Psychiatry Date: 1997-07 Impact factor: 8.829
Authors: Tzvetan Popov; Todor Jordanov; Brigitte Rockstroh; Thomas Elbert; Michael M Merzenich; Gregory A Miller Journal: Biol Psychiatry Date: 2010-11-18 Impact factor: 13.382
Authors: Rachel Loewy; Melissa Fisher; Danielle A Schlosser; Bruno Biagianti; Barbara Stuart; Daniel H Mathalon; Sophia Vinogradov Journal: Schizophr Bull Date: 2016-02-22 Impact factor: 9.306
Authors: Naomi S Kort; Judith M Ford; Brian J Roach; Handan Gunduz-Bruce; John H Krystal; Judith Jaeger; Robert M G Reinhart; Daniel H Mathalon Journal: Biol Psychiatry Date: 2016-07-01 Impact factor: 13.382
Authors: Ian S Ramsay; Brian J Roach; Susanna Fryer; Melissa Fisher; Rachel Loewy; Judith M Ford; Sophia Vinogradov; Daniel H Mathalon Journal: Schizophr Res Date: 2020-01-29 Impact factor: 4.939
Authors: Nikolaos Koutsouleris; Lana Kambeitz-Ilankovic; Shalaila S Haas; Linda A Antonucci; Julian Wenzel; Anne Ruef; Bruno Biagianti; Marco Paolini; Boris-Stephan Rauchmann; Johanna Weiske; Joseph Kambeitz; Stefan Borgwardt; Paolo Brambilla; Eva Meisenzahl; Raimo K R Salokangas; Rachel Upthegrove; Stephen J Wood Journal: Neuropsychopharmacology Date: 2020-10-07 Impact factor: 7.853